General

When deciding whether to start Quentin Johnston this week, several factors merit close consideration. Johnston’s talent is undeniable-his blend of size, speed, and route-running ability makes him a legitimate deep-threat and red-zone target. Recent games indicate a promising upward trend; for example, if he’s been averaging around 5-7 receptions and consistently exceeding 70 yards per game, that signals he’s carving out a significant role in his offense. However, fantasy managers should also evaluate the quality of the opposing defense. If Johnston faces a secondary that struggles to contain explosive receivers or ranks poorly against the pass, it could enhance his chances for a big game.

Target share is another critical metric. If the data reveals that he’s commanding a healthy percentage of his team’s targets-especially in the red zone-it increases his probability of scoring touchdowns, a crucial factor in fantasy value. Additionally, consider his recent snap counts and injury reports. Even a minor lingering injury can hamper performance and reduce snap time, thereby diminishing fantasy upside. If he’s reported fully healthy and practicing at full capacity, that strengthens the case for starting him confidently.

Ultimately, the decision hinges on balancing his potential upside against matchup risks and health status. If alternative receivers on your roster have less favorable matchups or have been underperforming, Johnston could be the optimal play. Conversely, if the opposing defense is elite and he’s not 100%, you might explore safer options. Weigh these variables carefully to make a decision aligned with your team’s strategy and risk tolerance.

The decision to discontinue progesterone once menstruation begins is nuanced and should ideally be individualized, taking into account the purpose of progesterone use, a person’s menstrual patterns, and overall health status. Progesterone is indeed pivotal in regulating the menstrual cycle-it prepares the endometrium for potential pregnancy and supports the luteal phase. Abrupt cessation of progesterone after menstruation starts typically aligns with the natural hormone decline as the body transitions into the follicular phase, and in many cases, it may not cause adverse effects. However, the context matters significantly.

For individuals using progesterone therapeutically-for example, those managing endometriosis, amenorrhea, or undergoing fertility treatments-maintenance or tapering strategies are often recommended rather than an abrupt stop. In these situations, sudden withdrawal may destabilize hormone levels, potentially exacerbating symptoms or negatively impacting treatment outcomes. People with irregular cycles might also experience unpredictable responses if progesterone is discontinued without clinical guidance.

Dosage and formulation (oral, vaginal, injectable) can further influence how the body reacts during cessation. Lower doses might be easier to withdraw from, while higher doses might necessitate a gradual taper to prevent withdrawal symptoms or hormonal imbalance.

Ultimately, clinical evaluation and a thorough health history are essential. Healthcare providers generally advocate for a personalized approach, considering factors such as the indication for progesterone, cycle regularity, and patient tolerance. Close communication with a provider ensures safe management of hormonal therapies, tailored to the individual’s unique physiological response and therapeutic goals. In summary, while discontinuing progesterone post-menstruation is common, doing so should be informed by medical advice rather than assumption.